"This partnership is a powerful example o how novel care models can complement traditional care to expand access," said Victor Sadauskas, MD, CEO of Kivo Health. "Together with Priority Health, we're ...
Zacks Investment Research on MSN
GSK stock up almost 19% in 3 months: Should you buy, hold or sell?
GSK GSK stock has risen 18.6% in the past three months. The price recovery was backed by strong third-quarter results, ...
The first participant was recruited within 103 days, significantly ahead of the government’s target to reduce commercial trial setup times to under 150 days. Being the first country to recruit a ...
With lung conditions the third biggest killer in Northern Ireland, Asthma + Lung UK Northern Ireland is calling for better ...
Non-cystic fibrosis bronchiectasis (NCFB) is a heterogeneous disease characterised by a ‘vicious vortex’ of ...
Major advancements in pulmonary fibrosis treatment and critical warnings regarding both indoor air quality and scientific ...
More than 11.7 million Americans live with chronic obstructive pulmonary disease (COPD), and West Virginia has one of the highest rates in the country, with more than 186,000 adults affected.
ERJ Open Research article reports first clinical trial of glasmacinal (EP395) in COPD patientsGlasmacinal, a novel macrolide, was well tolerated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback